104 related articles for article (PubMed ID: 1458005)
1. The chronicle of growth hormone receptor deficiency (Laron syndrome).
Rosenbloom AL
Acta Paediatr Suppl; 1992 Sep; 383():117-20. PubMed ID: 1458005
[No Abstract] [Full Text] [Related]
2. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
Gluckman PD; Ambler GR
Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
[No Abstract] [Full Text] [Related]
3. An update on Laron syndrome.
Laron Z
Arch Dis Child; 1993 Mar; 68(3):345-6. PubMed ID: 8466235
[No Abstract] [Full Text] [Related]
4. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
Laron Z
J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
[TBL] [Abstract][Full Text] [Related]
5. [Human insulin-like growth factor I and treatment in diabetes].
Koivisto VA
Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
[No Abstract] [Full Text] [Related]
6. Disorders of growth hormone resistance in childhood.
Laron Z
Curr Opin Pediatr; 1993 Aug; 5(4):474-80. PubMed ID: 8374676
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatment.
Carel JC; Chaussain JL; Chatelain P; Savage MO
Diabetes Metab; 1996 Jul; 22(4):251-6. PubMed ID: 8767171
[TBL] [Abstract][Full Text] [Related]
8. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
[No Abstract] [Full Text] [Related]
9. Clinical and biochemical characteristics of growth hormone receptor deficiency (Laron syndrome).
Rosenbloom AL; Savage MO; Blum WF; Guevara-Aguirre J; Rosenfeld RG
Acta Paediatr Suppl; 1992 Sep; 383():121-4. PubMed ID: 1458006
[No Abstract] [Full Text] [Related]
10. Growth hormone-receptor gene in Laron dwarfism.
Bass S; Wells J
N Engl J Med; 1990 Mar; 322(12):854-5. PubMed ID: 2308623
[No Abstract] [Full Text] [Related]
11. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
12. Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.
Amselem S; Sobrier ML; Duquesnoy P; Rappaport R; Postel-Vinay MC; Gourmelen M; Dallapiccola B; Goossens M
J Clin Invest; 1991 Mar; 87(3):1098-102. PubMed ID: 1999489
[TBL] [Abstract][Full Text] [Related]
13. [Growth hormone receptor and dwarfism].
Postel-Vinay MC
Rev Prat; 1994 May; 44(10):1281-5. PubMed ID: 7939185
[TBL] [Abstract][Full Text] [Related]
14. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
15. [Laron syndrome by loss of functions of growth hormone receptor].
Kaji H
Nihon Rinsho; 2002 Feb; 60(2):306-12. PubMed ID: 11857918
[TBL] [Abstract][Full Text] [Related]
16. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups.
Shevah O; Rubinstein M; Laron Z
Isr Med Assoc J; 2004 Oct; 6(10):630-3. PubMed ID: 15473594
[TBL] [Abstract][Full Text] [Related]
17. Point mutations in the growth hormone receptor gene of patients with Laron syndrome.
Amselem S; Duriez B; Sobrier ML; Duquesnoy P; Goossens M
Acta Paediatr Suppl; 1992 Sep; 383():132-3. PubMed ID: 1458008
[No Abstract] [Full Text] [Related]
18. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
[TBL] [Abstract][Full Text] [Related]
19. Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
Edery M; Rozakis-Adcock M; Goujon L; Finidori J; Lévi-Meyrueis C; Paly J; Djiane J; Postel-Vinay MC; Kelly PA
J Clin Invest; 1993 Mar; 91(3):838-44. PubMed ID: 8450064
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
